Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the...
Read moreNEWS RELEASE: MGS MFG. Group acquires Danish product design firm Technolution Members of Technolution and MGS Mfg. Group GERMANTOWN, Wis....
Read moreIn a recent study published in the Nutrients Journal, researchers explored the phytochemical contents and health benefits of consuming figs....
Read moreDeviceTalks Editorial Director Tom Salemi (left) interviewed Boston Scientific CEO Mike Mahoney (right) in front of a crowd of medtech...
Read more
© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
